

| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $193.0M | +17.7% |
| Cost of Revenue | $83.6M | +32.6% |
| Gross Profit | $109.4M | +8.4% |
| R&D Expense | $44.2M | +26.7% |
| SG&A Expense | $44.0M | +26.8% |
| Operating Income | -$27.8M | -1443.5% |
| Interest Expense | $2.1M | -19.5% |
| Pre-tax Income | -$15.7M | -1346.7% |
| Income Tax | -$3.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.3M | -43.6% |
| Accounts Receivable | $55.9M | +14.5% |
| Inventory | $60.9M | +26.4% |
| Current Assets | $392.1M | -13.6% |
| Total Assets | $494.5M | -4.8% |
| Current Liabilities | $56.2M | +14.7% |
| Total Liabilities | $101.4M | +7.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.3M | +143.2% |
| Capital Expenditures | $4.6M | -52.3% |
| Investing Cash Flow | -$93.9M | -67.9% |
| Financing Cash Flow | -$41.8M | -858.4% |
| Free Cash Flow | $633K | +102.9% |
| -190.9% |
| Net Income | -$12.1M | -589.0% |
| EPS (Basic) | -$0.09 | -550.0% |
| EPS (Diluted) | -$0.09 | -550.0% |
| Stockholders' Equity |
| $393.1M |
| -7.6% |